1. D.S. Ettinger, W. Akerley, H. Borghaei, A.C. Chang, R.T. Cheney, L.R. Chirieac, T.A. D'Amico, T.L. Demmy, R. Govindan, F.W. Grannis, Jr., S.C. Grant, L. Horn, T.M. Jahan, R. Komaki, F.M. Kong, M.G. Kris, L.M. Krug, R.P. Lackner, I.T. Lennes, B.W. Loo, Jr., R. Martins, G.A. Otterson, J.D. Patel, M.C. Pinder-Schenck, K.M. Pisters, K. Reckamp, G.J. Riely, E. Rohren, T.A. Shapiro, S.J. Swanson, K. Tauer, D.E. Wood, S.C. Yang, K. Gregory, M. Hughes, Non-small cell lung cancer, version 2.2013, J. Natl. Compr. Canc. Netw., 11 (2013) 645-653; quiz 653.
2. Cancer statistics CA Cancer;Siegel;J. Clin.,2013
3. J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 136 (2015) E359-386.
4. The quest to overcome resistance to EGFR-targeted therapies in cancer;Chong;Nat. Med.,2013
5. MYC amplification as a potential mechanism of primary resistance to crizotinib in ALK-rearranged non-small cell lung cancer: a brief report;Rihawi;Transl. Oncol.,2018